Clinical Trial Update: A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating two second-line combination antiretroviral therapy options after virological failure of a standard NNRTI plus two NRTIs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2014-01-17